PMBCX
Price
$29.82
Change
-$0.44 (-1.45%)
Updated
Jun 3 closing price
Net Assets
24.29B
TRMNX
Price
$24.38
Change
-$0.20 (-0.81%)
Updated
Jun 3 closing price
Net Assets
484.38M
Interact to see
Advertisement

PMBCX vs TRMNX

Header iconPMBCX vs TRMNX Comparison
Open Charts PMBCX vs TRMNXBanner chart's image
PMBCX vs TRMNX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. TRMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and TRMNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.3B vs. TRMNX (484M). TRMNX pays higher dividends than PMBCX: TRMNX (0.67) vs PMBCX (0.00). PMBCX was incepted earlier than TRMNX: PMBCX (19 years) vs TRMNX (10 years). PMBCX (1.71) is less costly to investors than TRMNX (0.90). TRMNX is a more actively managed with annual turnover of: 39.30 vs. PMBCX (13.70). PMBCX has a lower initial minimum investment than TRMNX: PMBCX (1000) vs TRMNX (2500). TRMNX annual gain was more profitable for investors over the last year : 16.93 vs. PMBCX (-15.97). TRMNX return over 5 years is better than : 27.89 vs. PMBCX (-10.31).
PMBCXTRMNXPMBCX / TRMNX
Total Expense Ratio1.710.27633%
Annual Report Gross Expense Ratio1.710.90190%
Fund Existence19 years10 years-
Gain YTD-7.80011.222-70%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets24.3B484M5,021%
Annual Yield % from dividends0.000.67-
Returns for 1 year-15.9716.93-94%
Returns for 3 years9.3265.0914%
Returns for 5 years-10.3127.89-37%
Returns for 10 years52.29157.8833%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMNT0.230.01
+2.24%
Perfect Moment Ltd
JANX13.57-0.21
-1.52%
Janux Therapeutics
KMB94.76-2.73
-2.80%
Kimberly-Clark Corp
SOUN8.07-0.75
-8.47%
SoundHound AI
NRXP4.05-0.58
-12.45%
NRX Pharmaceuticals